Download presentation
Presentation is loading. Please wait.
Published byPoppy Copeland Modified over 9 years ago
1
Richard Croft Diabetes Lead Berkshire West
2
The impact of a 1% reduction in HbA1c
4
((There is no correlation at all!)
5
Think: why is he testing? What will he do with the result? What will YOU do with the result?
6
Diabetics who use insulin – Type 1, and Type 2 who use insulin Women with gestational diabetes Some patients who use sulphonylureas (eg gliclazide), especially if they drive Other patients with intercurrent illness
7
Everybody else!!
8
To detect hypo- and hyper-glycaemia in diabetics who use insulin (and SUs) To help patients prevent immediate serious illness (hypoglycaemic attacks and DKA) As part of the long-term management of diabetes to maintain good control and prevent micro- and macro- vascular complications
9
In Type 1 DM ◦ Before meals 4-7mmol/l ◦ 2hrs after meals < 9mmol/l In Type 2 DM ◦ Before meals4-7mmol/l ◦ 2 hrs after meals< 8.5mmol/l
10
Twice daily insulin therapy – Test 2-3x day, varying testing times between fasting, premeal and postmeal to identify trends Intensive insulin therapy (basal bolus) – Monitor 2-4x day normally – Monitor at least 4x day if they alter doses at mealtimes More frequent testing during intercurrent illness
11
Twice daily insulin regime – Test 1-2x day varying times between fasting, premeal and postmeal Intensive insulin therapy (basal bolus) – Monitor 2-4x day normally – Monitor at least 4x day if they alter doses at mealtimes Once daily insulin (basal regime) – Test fasting BG once daily during initiation, can then be reduced to 1-2x week)
12
Naseem is going to talk some more about testing in Type 1 diabetes We are going to introduce carbohydrate counting as a means of improving control in people with Type 1, and a very smart device to help patients calculate their correct dose of insulin
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.